RDHL.O (RDHL.O) News
Follow RDHL.O (RDHL.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
RedHill Biopharma raises maximum size of ATM ADS offering under H.C. Wainwright agreement
RedHill Biopharma filed a prospectus supplement raising the maximum aggregate amount of ADSs it may sell under its at-the-market offering program. The ADS sales are made from time to time under an equity distribution agr
EARNINGS | Oct 13, 2026, 08:11 PM UTC
M
RedHill Biopharma wins Nasdaq extension to regain $1 minimum bid compliance by April 5, 2027
Nasdaq set a new compliance deadline of April 5, 2027 after an initial period ended Oct. 5, 2026; Nasdaq will close the matter if the ADS bid stays at or above $1.00 for 10 straight business days.
EQUITY | Oct 07, 2026, 12:06 PM UTC